Bluejay Diagnostics Inc. (BJDX)
2.30
-0.04 (-1.71%)
At close: Apr 15, 2025, 3:59 PM
2.33
1.25%
After-hours: Apr 15, 2025, 05:49 PM EDT
-1.71% (1D)
| Bid | 2.22 |
| Market Cap | 1.27M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.72M |
| EPS (ttm) | -114.19 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | -12.38 |
| Analyst | n/a |
| Ask | 2.57 |
| Volume | 293,230 |
| Avg. Volume (20D) | 1,138,114 |
| Open | 2.37 |
| Previous Close | 2.34 |
| Day's Range | 2.19 - 2.50 |
| 52-Week Range | 2.17 - 316.80 |
| Beta | 0.35 |
About BJDX
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reag...
Industry Medical - Devices
Sector Healthcare
IPO Date Nov 10, 2021
Employees 7
Stock Exchange NASDAQ
Ticker Symbol BJDX
Website https://www.bluejaydx.com
4 months ago
+59.38%
Bluejay Diagnostics shares are trading higher afte...
Unlock content with
Pro Subscription
5 months ago
-28.85%
Bluejay Diagnostics shares are trading lower after the company announced a 1-for-50 reverse stock split.
